Gemayel says that aside from the giveaway, Roche has a clear marketing message for the new treatment, which combats hepatitis C virus and the chronic liver disease it causes.
The FDA has announced that it has approved a new drug to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C) in adults.